The thalassaemias.
作者信息
Weatherall D J
机构信息
Institute of Molecular Medicine, John Radcliffe Hospital, Oxford.
出版信息
BMJ. 1997 Jun 7;314(7095):1675-8. doi: 10.1136/bmj.314.7095.1675.
Abstract
摘要
相似文献
1
The thalassaemias.地中海贫血
BMJ. 1997 Jun 7;314(7095):1675-8. doi: 10.1136/bmj.314.7095.1675.
2
Thalassemia in SouthEast Asia: problems and strategy for prevention and control.东南亚的地中海贫血：预防与控制的问题及策略
Southeast Asian J Trop Med Public Health. 1992 Dec;23(4):647-55.
3
The thalassaemia syndromes.
Q J Med. 1993 Sep;86(9):559-64.
4
Problems in determining thalassemia carrier status in a program for prevention and control of severe thalassemia syndromes: a lesson from Thailand.在预防和控制重型地中海贫血症计划中确定地中海贫血携带者状态时存在的问题：来自泰国的经验教训。
Clin Chem Lab Med. 2013 Aug;51(8):1605-14. doi: 10.1515/cclm-2013-0098.
5
Molecular genetics and prenatal diagnosis of the thalassaemias.
Malays J Pathol. 1997 Jun;19(1):1-9.
6
Two thalassemia intermedia patients with delta beta/beta-thalassemia and a deletional type alpha-thalassemia.
Haematologica. 2001 Jan;86(1):108.
7
Premarital screening for thalassemia in mainland China.中国大陆的婚前地中海贫血筛查。
Prenat Diagn. 2009 Jun;29(6):637-8. doi: 10.1002/pd.2251.
8
Prevention of beta-thalassemia major and Hb Bart's hydrops fetalis syndrome.重型β地中海贫血和血红蛋白Bart水肿胎儿综合征的预防。
Semin Hematol. 1995 Oct;32(4):244-61.
9
[Large-scale population-based genetic screening and prenatal diagnosis for thalassemias in Zhuhai City of Guangdong Province].[广东省珠海市地中海贫血的大规模人群基因筛查与产前诊断]
Zhonghua Fu Chan Ke Za Zhi. 2012 Feb;47(2):90-5.
10
[Thalassemia. Physiopathology and diagnosis].
Rev Prat. 1994 Feb 15;44(4):522-8.
引用本文的文献
1
Iron and Bone Pathophysiology.铁与骨的病理生理学
Adv Exp Med Biol. 2025;1480:311-325. doi: 10.1007/978-3-031-92033-2_20.
2
Hemoglobin Variants as Targets for Stabilizing Drugs.作为稳定药物靶点的血红蛋白变体
Molecules. 2025 Jan 17;30(2):385. doi: 10.3390/molecules30020385.
3
Hereditary non-spherocytic hemolytic anemia with GPI mutations successfully treated with allogeneic hematopoietic stem cell transplantation: a first report of two cases.伴有糖基磷脂酰肌醇（GPI）突变的遗传性非球形红细胞溶血性贫血经异基因造血干细胞移植成功治疗：两例首例报告
J Mol Med (Berl). 2025 Mar;103(3):265-271. doi: 10.1007/s00109-025-02514-3. Epub 2025 Jan 21.
4
Development and clinical validation of a novel detection kit for α-thalassemia in southern Chinese.一种针对中国南方人群的新型α地中海贫血检测试剂盒的研发与临床验证
Front Genet. 2024 Sep 5;15:1457248. doi: 10.3389/fgene.2024.1457248. eCollection 2024.
5
Magnetic Resonance Evaluation of Tissue Iron Deposition and Cardiac Function in Adult Regularly Transfused Thalassemia Intermedia Compared with Thalassemia Major Patients.与重型地中海贫血患者相比，成人中间型地中海贫血定期输血患者组织铁沉积和心脏功能的磁共振评估
J Clin Med. 2024 Aug 14;13(16):4791. doi: 10.3390/jcm13164791.
6
Iron and bones: effects of iron overload, deficiency and anemia treatments on bone.铁与骨骼：铁过载、铁缺乏及贫血治疗对骨骼的影响
JBMR Plus. 2024 May 14;8(8):ziae064. doi: 10.1093/jbmrpl/ziae064. eCollection 2024 Aug.
7
Multiparametric cardiac magnetic resonance in patients with thalassemia intermedia: new insights from the E-MIOT network.中间型地中海贫血患者的心脏磁共振多参数成像：E-MIOT 网络的新见解。
Radiol Med. 2024 Jun;129(6):879-889. doi: 10.1007/s11547-024-01821-y. Epub 2024 Apr 29.
8
Impact of genotype on multi-organ iron and complications in patients with non-transfusion-dependent β-thalassemia intermedia.基因型对非输血依赖型β-中间型地中海贫血患者多器官铁沉积及并发症的影响。
Ann Hematol. 2024 Jun;103(6):1887-1896. doi: 10.1007/s00277-024-05741-9. Epub 2024 Apr 6.
9
Phenotypic Clustering of Beta-Thalassemia Intermedia Patients Using Cardiovascular Magnetic Resonance.利用心血管磁共振成像对中间型β地中海贫血患者进行表型聚类分析
J Clin Med. 2023 Oct 24;12(21):6706. doi: 10.3390/jcm12216706.
10
Impact of the COVID-19 Pandemic on Iron Overload Assessment by MRI in Patients with Hemoglobinopathies: The E-MIOT Network Experience.COVID-19 大流行对血红蛋白病患者 MRI 铁过载评估的影响：E-MIOT 网络的经验。
Tomography. 2023 Sep 11;9(5):1711-1722. doi: 10.3390/tomography9050136.
Zotero 插件